找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach; Nima Rezaei Book 2024 The Editor(s) (if applicable)

[复制链接]
楼主: ISSUE
发表于 2025-3-28 15:01:47 | 显示全部楼层
Molecular Genetics of Breast Cancer: From Mechanistic Insights to the Therapeutic Approaches, and polygenic risk scores are essential for identifying target genes and predicting risk. Current treatments for breast cancer include chemotherapy, targeted therapy, and immunotherapies, with ongoing research focusing on improving long-term benefits for patients.
发表于 2025-3-28 21:10:12 | 显示全部楼层
Interleukins in the Development and Progression of Breast Cancer,re associated with acute inflammatory processes, including IL-8 and IL-12, whereas some with chronic inflammatory responses include IL-2, IL-3, IL-6, IL-10, IL-12, and others. Moreover, chronic inflammation leads to different signaling mechanisms and transcription factors and alters both the patient
发表于 2025-3-29 00:35:57 | 显示全部楼层
发表于 2025-3-29 07:04:39 | 显示全部楼层
发表于 2025-3-29 08:57:31 | 显示全部楼层
发表于 2025-3-29 14:07:19 | 显示全部楼层
发表于 2025-3-29 18:49:38 | 显示全部楼层
发表于 2025-3-29 19:52:15 | 显示全部楼层
Oncolytic Virotherapy Against Breast Cancer,apeutic agents for synergistic effects. The efficacy of oncolytic viruses has been substantiated through numerous preclinical investigations and more recently in human trials. Notably, the US Food and Drug Administration has granted approval for the utilization of talimogene laherparepvec, an oncoly
发表于 2025-3-30 00:15:08 | 显示全部楼层
发表于 2025-3-30 06:11:44 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-29 09:51
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表